25.08.2021 • NewsClariant

Clariant Acquires Remaining 70% of Beraca

Swiss specialty chemicals producer Clariant has agreed to acquire the remaining 70% of Brazilian Personal Care Specialties company Beraca after taking a 30% stake in 2015. Seller is the founding Sabará family. Financial terms of the acquisition expected to close in this year’s fourth quarter were not disclosed.

Based in the Amazon region, Beraca is one of the key manufacturers of natural ingredients for the personal care sector with a portfolio composed in particular of fats, oils and botanicals that are collected and extracted in an environmentally sustainable production process.

The family-run company with 90 employees and 2020 sales of $15 million has invested significant resources in expanding research and innovation and has steadily increased production capacity. It has won several awards for its ethical sourcing.

With the purchase, which he described as “a building block in the strategy of further strengthening individual core business areas through targeted acquisitions,” the Swiss group’s CEO, Conrad Keijzer, said Clariant will gain valuable access to natural materials. based on the biodiversity of the Brazilian rainforest. This, he said, will open up opportunities for high-quality growth in its Care Chemicals business, into which the acquisition will be integrated.

Having full control of Beraca will mean that Clariant is well placed  to meet the increasing demand for ethically produced products on the world market, added Christian Vang, head of Industrial & Consumer Specialties business unit.

Author: Dede Williams, Freelance Journalist

Clariant has agreed to acquire the remaining 70% of Brazilian Personal Care...
Clariant has agreed to acquire the remaining 70% of Brazilian Personal Care Specialties company Beraca after taking a 30% stake in 2015. Seller is the founding Sabará family. Financial terms of the acquisition expected to close in this year’s fourth quarter were not disclosed. (c) Clariant

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read